Tag - Restores Vision to Blind Patients

CRISPR Partially Restores Vision to Blind Patients During Trial

Results from a Phase 1/2 clinical trial indicate that CRISPR gene-editing has enhanced the vision of individuals with inherited blindness, offering promising prospects for patients and suggesting broader applications of CRISPR in human therapeutics.Leber Congenital Amaurosis (LCA) is a rare disorder affecting approximately one in every 40,000 newborns. Individuals with LCA carry a genetic...